U.S. federal trademark · Serial No. 99213731 · Reg. No. 8319087
Platform as a service (PAAS) featuring computer software platforms for for data analysis, drug discovery, drug screening, and preclinical testing in the field of bioinformatics; Research and development in the field of bioinformatics; Research and development in the field of cancer treatment and diagnosis; Drug discovery services; Drug screening for scientific research purposes; Testing of pharmaceuticals for cell and gene therapies; Research and development in the field of cell reprogramming technology for therapeutic applications; Research and development in the field of epigenomic modification for cellular medicine; Research and development in the field of enhancing cell and gene therapies; Research and development in the field of immune cell enhancement and rejuvenation; Research and development in the field of cell therapy enhancement for treatment of cancer, viral infections, and autoimmune disorders; Research and development in the field of therapeutic kits and solutions for cellular medicine; Platform as a service (PAAS) featuring computer software platforms for for enhancing cellular function and longevity; Consulting services in the field of pharmaceutical research; Consulting services in the field of biotechnology; Consulting services in the field of genetic science
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.